InvestorsHub Logo
Followers 32
Posts 12644
Boards Moderated 0
Alias Born 08/29/2012

Re: jour_trader post# 373998

Friday, 09/23/2022 9:52:09 AM

Friday, September 23, 2022 9:52:09 AM

Post# of 401936
LMAO.

Elite's relationship with Lannett is INCREASING.


Jun 29, 2022
Elite Pharmaceuticals Receives FDA Approval For Generic Sabril®
NORTHVALE, NJ / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it received approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application (ANDA) for a generic version of Sabril® (Vigabatrin USP) 500 mg powder for solution packet. Lannett Company, Inc. has an exclusive license to market and distribute the product in the U.S. and territories.


PS: And I didn't even mention LANNETT is our partner for Dantrolene..........and the partnership was JUST extended last year for an additional 2 YEARS.

https://s3.amazonaws.com/sec.irpass.cc/2258/0001493152-21-030252.pdf

Lannett relationship dissolving




----------------------------------------------------------------------------------------------------------------------------------

MAKE ELITE GREAT AGAIN!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News